Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Advances in genome editing for genetic hearing loss.

Advanced drug delivery reviews - 1 Jan 2021

Ding Ning, Lee Sangsin, Lieber-Kotz Matan, Yang Jie, Gao Xue

Abstract excerpt

According to the World Health Organization, hearing loss affects over 466 million people worldwide and is the most common human sensory impairment. It is estimated that genetic factors contribute to the causation of approximately 50% of congenital hearing loss. Yet, curative approaches to reversing or preventing genetic hearing impairment are still limited. The clustered regularly interspaced short palindromic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Clustered Regularly Interspaced Short Palindromic Repeats
Share to Gene Editing

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Therapy

Share to Hearing Loss

Share to Polymorphism, Single Nucleotide

Source

Open in PubMed Open full text

Identifiers

PMID: 32387678
DOI: 10.1016/j.addr.2020.05.001
PMCID: PMC7647959

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Advances in genome editing for genetic hearing loss.PMID 32387678Read ↗

The application of genome editing in studying hearing loss.Semantic proximity Read ↗

CRISPR/Cas9: targeted genome editing for the treatment of hereditary hearing loss.Semantic proximity Read ↗

Gene therapy for hereditary hearing loss.Semantic proximity Read ↗

Gene therapy for hearing loss.Semantic proximity Read ↗

Gene Therapy for Inherited Hearing Loss: Updates and Chal-lengesSemantic proximity Read ↗

Novel CRISPR/Cas12a-based genetic diagnostic approach for SLC26A4 mutation-related hereditary hearing loss.Semantic proximity Read ↗

The development of inner ear gene therapy for DFNB9: From bench to bedside.Semantic proximity Read ↗

Deafness in the genomics era.Semantic proximity Read ↗

Gene therapy for genetic mutations affecting non-sensory cells in the cochlea.Semantic proximity Read ↗

Usher Syndrome in the Inner Ear: Etiologies and Advances in Gene Therapy.Semantic proximity Read ↗

Treatment of autosomal dominant hearing loss by in vivo delivery of genome editing agents.Semantic proximity Read ↗

Treatment of monogenic and digenic dominant genetic hearing loss by CRISPR-Cas9 ribonucleoprotein delivery in vivoSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.